A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA. [electronic resource]
Producer: 20080501Description: 1216-23 p. digitalISSN:- 1460-2385
- Adult
- Age Distribution
- Aged
- Aged, 80 and over
- Angiotensin II Type 1 Receptor Blockers -- economics
- Cost-Benefit Analysis
- Diabetes Mellitus, Type 2 -- complications
- Disease-Free Survival
- Female
- Health Care Costs
- Humans
- Hypertension -- complications
- Hypoglycemic Agents -- therapeutic use
- Incidence
- Kidney Failure, Chronic -- complications
- Life Expectancy -- trends
- Male
- Mass Screening -- economics
- Middle Aged
- Models, Economic
- Morbidity -- trends
- Prognosis
- Quality of Life
- Renal Insufficiency -- drug therapy
- Survival Rate -- trends
- United States -- epidemiology
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.